Building on these molecular mechanisms, our KEGG enrichment analysis reveals that THSW Decoction treats liver fibrosis mainly involves the Phosphatidylinositol-3-Kinase/Protein Kinase B(PI3K-Akt) pathway, along with estrogen, relaxin, and Mitogen-Activated Protein Kinase (MAPK) signaling pathways. The gene discussed is AKT1; the disease is Hepatic fibrosis.